{"organizations": [], "uuid": "c583e1e20f9596b35b7d7ae31fa2b1f767e6c0c1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-envision-healthcare-sees-q4-revenu/brief-envision-healthcare-sees-q4-revenue-about-2-0-bln-idUSASB0C4MS", "country": "US", "domain_rank": 408, "title": "BRIEF-Envision Healthcare Sees Q4 Revenue About $2.0 Bln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T23:38:00.000+02:00", "replies_count": 0, "uuid": "c583e1e20f9596b35b7d7ae31fa2b1f767e6c0c1"}, "author": "", "url": "https://www.reuters.com/article/brief-envision-healthcare-sees-q4-revenu/brief-envision-healthcare-sees-q4-revenue-about-2-0-bln-idUSASB0C4MS", "ord_in_thread": 0, "title": "BRIEF-Envision Healthcare Sees Q4 Revenue About $2.0 Bln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-envision healthcare", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "reuters) - envision healthcare corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 7, 2018 / 9:40 PM / Updated 3 minutes ago BRIEF-Envision Healthcare Sees Q4 Revenue About $2.0 Bln Reuters Staff \nFeb 7 (Reuters) - Envision Healthcare Corp: \n* ENVISION PROVIDES PRELIMINARY 2017 FOURTH QUARTER RESULTS * SEES Q4 2017 REVENUE ABOUT $2.0 BILLION * ‍EXTENDS DIRECTOR NOMINATION DEADLINE TO MARCH 16, 2018​ \n* FOR THREE MONTHS ENDED DEC. 31, 2017, EXPECTS TO REPORT NET REVENUE FROM CONTINUING OPERATIONS OF ABOUT $2 BILLION \n* ‍SEES QTRLY ADJUSTED EBITDA FROM CONTINUING OPERATIONS WILL BE AT, OR SLIGHTLY ABOVE, HIGH END OF ITS GUIDANCE RANGE OF $182 MILLION TO $202 MILLION​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-07T23:38:00.000+02:00", "crawled": "2018-02-07T23:50:40.022+02:00", "highlightTitle": ""}